Serum zonulin levels in patients with liver cirrhosis: Prognostic implications

Table 1 Baseline clinical and laboratory characteristics of the patients

Examined parameter		Baseline value
Sex as M/F, n (%)		71/45 (61.2)
Age in yr1		59 ± 13
BMI, kg/m2		27.5 ± 5.0
Liver disease etiology, n (%)
	Chronic hepatitis B	25 (21.6)
	Chronic hepatitis C	20 (17.2)
	Alcohol abuse	35 (30.2)
	NAFLD	20 (17.2)
	Autoimmune hepatitis	5 (4.3)
	Other	11 (9.5)
CTP class, n (%)
	A	78 (67.2)
	B	33 (28.4)
	C	5 (4.4)
	CTP score	6.2 ± 1.6
MELD score		11.0 ± 3.9
Decompensated cirrhosis, n (%)		61 (52.6)
History of HE, n (%)		37 (31.9)
Ascites, n (%)		56 (48.3)
Bilirubin in mg/dL		1.3 ± 0.9
Creatinine in mg/dL		1.0 ± 1.2
Albumin in g/L		41.0 ± 4.0
Platelet count as × 109/L		121 ± 49
INR		1.3 ± 0.3

¹Quantitative variables are expresses as mean ± SD.

BMI: Body mass index; CTP: Child-Turcotte-Pugh; F: Female; HE: Hepatic encephalopathy; INR: International normalized ratio; M: Male; MELD: Model for end-stage liver disease; NAFLD: Nonalcoholic fatty liver disease.